Feng Wu

4.3k citations

60 papers · 2.5k indexed · h-index 30

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Infectious Diseases top 5%
- COVID-19 Clinical Research Studies

Papers in

Cancer Research 12
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
Aging 1

Co-authors: Yang Jin Juanjuan Xu Jinshuo Fan Mengfei Guo Zhilei Lv Limin Duan Guorong Hu Guanghai Yang
Journals: Oncogene (4 papers)Frontiers in Immunology (3 papers)Molecular Cancer (3 papers)Journal of Cancer (2 papers)Scientific Reports (2 papers)
Partner nations: China Hong Kong United States

In The Last Decade

Feng Wu

60 papers receiving 2.5k citations

Peers

Countries citing papers authored by Feng Wu

Since Specialization

Citations

This map shows the geographic impact of Feng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Wu more than expected).

Fields of papers citing papers by Feng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Wu. The network helps show where Feng Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Feng Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Wu Line = papers co-authored together Feng Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway Cell & Bioscience ·Yumei Li, Pei Ma, Jingxia Li, Feng Wu, Mengfei Guo, Enping Zhou, Siwei Song, Sufei Wang, Shuai Zhang, Yang Jin	2024	5
2	Exploring the evolving roles and clinical significance of circRNAs in head and neck squamous cell carcinoma Journal of Cancer ·Maria A. Trosheva, Xiaoguang You, R. Poornima, Hui Liu, C. Habermann, Feng Wu, Chanakya Tripathi, Xiaolong Zhang, Ke Zhao, Shuxin Wen, Wei Gao, S V Andreias	2024	2
3	Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer The FASEB Journal ·Xiaoqiang Qi, Feng Wu, Sung Hoon Kim, Jussuf T. Kaifi, Eric T. Kimchi, 장병철, Anuradha Illendula, Todd E. Fox, Mark Kester, Kevin F. Staveley-O’Carroll, Guangfu Li	2022	13
4	Phytonutrients: Sources, bioavailability, interaction with gut microbiota, and their impacts on human health Frontiers in Nutrition ·Juntao Kan, Feng Wu, Vargáné Hajdú P, Jianheng Zheng, Junrui Cheng, Yuan Li, Yuexin Yang, Jun Du	2022	31
5	NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway Oncogene ·Wei Kang, Jinglin Zhang, Tingting Huang, Yuhang Zhou, Chi Chun Wong, Ronald Chan, Yujuan Dong, Feng Wu, Bin Zhang, William Ka Kei Wu, Michael W.Y. Chan, Alfred S.L. Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, Ka‐Fai To	2021	26
6	Tunning Intermolecular Interaction of Peptide-Conjugated AIEgen in Nano-Confined Space for Quantitative Detection of Tumor Marker Secreted from Cells Analytical Chemistry ·Feng Wu, Yu Huang, Xian Yang, Jingjing Hu, Xiaoding Lou, Fan Xia, Yanlin Song, Lei Jiang	2021	28
7	FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential Oncogene ·Jinglin Zhang, Chi Chun Wong, Kam Tong Leung, Feng Wu, Yuhang Zhou, Joanna H. Tong, Ronald Chan, Hui Li, Yifei Wang, Huan Yan, Liping Liu, William Ka Kei Wu, Michael W.Y. Chan, Alfred S.L. Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, Ka‐Fai To, Wei Kang	2020	33
8	AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis Oncogene ·Yuhang Zhou, Jinglin Zhang, Hui Li, Tingting Huang, Chi Chun Wong, Feng Wu, Man Wu, Woojoo Shim, Liping Liu, Alfred S.L. Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, Patrick Ming‐Kuen Tang, Wei Kang, Ka‐Fai To	2020	34
9	Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study Clinical Microbiology and Infection ·Shuai Zhang, Mengfei Guo, Feng Wu, Nian Xiong, Yanling Ma, Zhihui Wang, Limin Duan, Lan Chen, Carmen Añazco, Yang Jin	2020	23
10	Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study Bioorganic Chemistry ·Qi Tan, Limin Duan, Yanling Ma, Feng Wu, Qi Huang, Kaimin Mao, Wenjing Xiao, Hui Xia, Shujing Zhang, Enping Zhou, Pei Ma, Siwei Song, Yumei Li, Zilin Zhao, 忠平山内, Zeyu Li, Wei Geng, Deize LUTKE, Yang Jin	2020	66
11	Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis European Journal of Cancer ·Sufei Wang, Pei Ma, Carl W. Griffin, Zhilei Lv, Feng Wu, Mengfei Guo, Yumei Li, (unknown), Qi Tan, Siwei Song, Enping Zhou, Wei Geng, Yanran Duan, Astrid Robin Van Aggelen, Astrid Robin Van Aggelen, Yang Jin	2019	36
12	Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer Genomics ·Jinshuo Fan, Zhongyuan Yin, Juanjuan Xu, Feng Wu, Qi Huang, Lin Yang, Yang Jin, Guanghai Yang	2019	63
13	The multifaceted roles of FOXM1 in pulmonary disease Cell Communication and Signaling ·Yumei Li, Feng Wu, Lijun Shi, Mengfei Guo, Pei Ma, Xuan Wang, Shuai Zhang, Juanjuan Xu, Ping Luo, Yang Jin	2019	40
14	Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation Frontiers in Immunology ·Guorong Hu, Mengfei Guo, Juanjuan Xu, Feng Wu, Jinshuo Fan, Qi Huang, Guanghai Yang, Zhilei Lv, Xuan Wang, Yang Jin	2019	185
15	EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer Molecular Carcinogenesis ·Yi Pan, Joanna H.M. Tong, Wei Kang, Raymond Wai Ming Lung, Wing P. Chak, Lau Y. Chung, Feng Wu, Hui Li, Jun Yu, Anthony W.H. Chan, Ka‐Fai To	2018	16
16	FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p Oncogene ·Jinglin Zhang, Yuhang Zhou, Tingting Huang, Feng Wu, Yi Pan, Yujuan Dong, Yan Wang, Aden Ka‐Yin Chan, Liping Liu, Johnny S. H. Kwan, Alvin H.K. Cheung, Chi Chun Wong, Angela Kwok Fung Lo, Alfred S.L. Cheng, Jun Yu, Kwok Wai Lo, Wei Kang, Ka‐Fai To	2018	43
17	Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis Frontiers in Immunology ·Jinshuo Fan, Zhilei Lv, Guanghai Yang, Kym Householder, Juanjuan Xu, Feng Wu, Qi Huang, Mengfei Guo, Guorong Hu, Mei Zhou, Limin Duan, Shuqing Liu, Yang Jin	2018	40
18	Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway Journal of Translational Medicine ·Yi Pan, ST Cheung, Joanna H.M. Tong, K.N. NIKOLAEV, Wei Kang, Raymond Wai Ming Lung, Feng Wu, Hui Li, Simon S.M. Ng, Tony Wing Chung Mak, Ka‐Fai To, Anthony W.H. Chan	2018	12
19	IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis Molecular Cancer ·Yuhang Zhou, Tingting Huang, 陈井阳, Chi Chun Wong, Yujuan Dong, Feng Wu, Bin Zhang, William Ka Kei Wu, Alfred S.L. Cheng, Jun Yu, Ka‐Fai To, Wei Kang	2017	115
20	The effect of proinflammatory cytokines on IL-17RA expression in NSCLC Medical Oncology ·Qi Huang, Jiao Du, Jinshuo Fan, Zhilei Lv, Xin Qian, Xiuxiu Zhang, Jieli Han, Caiyun Chen, Feng Wu, Yang Jin	2014	10

About Feng Wu

Feng Wu is a scholar working on Cancer Research, Aging, Immunology, Oncology and Molecular Biology, having authored 60 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (8 papers), Cancer-related molecular mechanisms research (6 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Cancer Research (577 citations), Infectious Diseases (397 citations), Oncology (461 citations), Molecular Biology (1.1k citations) and Immunology (309 citations). Feng Wu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yang Jin, Juanjuan Xu, Jinshuo Fan, Mengfei Guo, Zhilei Lv, Limin Duan, Guorong Hu, Guanghai Yang, Qi Huang and Pei Ma. Their work appears in journals such as Oncogene, Frontiers in Immunology, Molecular Cancer, Journal of Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact